Enanta Pharmaceuticals (ENTA) P/E (2013 - 2026)
Enanta Pharmaceuticals (ENTA) P/E from Mar 21, 2013 to Jul 21, 2026. The TTM Enanta Pharmaceuticals (ENTA) P/E is -2.42. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Enanta Pharmaceuticals (ENTA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.42 | -5.56% |
| 2025 | -2.56 | +119.89% |
| 2024 | -1.17 | -21.14% |
| 2023 | -1.48 | -66.70% |
| 2022 | -4.44 | -70.54% |
| 2021 | -15.06 | +3.25% |
| 2020 | -14.59 | -140.45% |
| 2019 | 36.06 | +126.69% |
| 2018 | 15.91 | -74.96% |
| 2017 | 63.54 | +119.20% |
| 2016 | 28.99 | +195.98% |
| 2015 | 9.79 | -15.29% |
| 2014 | 11.56 | -141.92% |
| 2013 | -27.58 | N/A |
Comparison Enanta Pharmaceuticals (ENTA) P/E with competitors
Enanta Pharmaceuticals (ENTA) P/E is -2.42.